Daniel B Fried
Affiliation: University of North Carolina
- Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancerDaniel B Fried
Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
J Clin Oncol 22:4837-45. 2004..In addition, we assessed the impact of radiation fractionation and chemotherapeutic regimen on timing...
- Current and evolving treatment options for limited stage small cell lung cancerCarrie B Lee
Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, 27599, USA
Curr Opin Oncol 18:162-72. 2006..Several targeted agents have also been evaluated. This review will highlight the data that have greatly impacted on the standard of limited stage small cell lung cancer care...
- Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysisMaria Q Baggstrom
Division of Medical Oncology, Washington University, St Louis, Missouri 63110, USA
J Thorac Oncol 2:845-53. 2007..To estimate the efficacy of third-generation (3G) chemotherapy agents (paclitaxel, docetaxel, gemcitabine, vinorelbine, and irinotecan) on response and survival in stage IIIB/IV non-small cell lung cancer (NSCLC)...